Fate of a Pregnant Women with Mixed Connective Tissue Disease in a Tertiary Care Hospital in India - A Case Report

Authors

  • Amisha Rathore Department of Obstetrics and Gynaecology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India
  • Bidisha Roy Choudhury Department of Obstetrics and Gynaecology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India
  • Akanksha Mishra Department of Obstetrics and Gynaecology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India
  • Rahul Deb Mondal Department of Obstetrics and Gynaecology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India

Keywords:

MCTD, termination of pregnancy.

Abstract

 Mixed connective tissue disease (MCTD) is a term involving the features of lupus systemic sclerosis, polymyositis, rheumatoid arthritis and high titre of anti ribonucleoprotein (RNP) antibodies however the exact etiology of the disease is not known. MCTD is characterized by microvascular damage, along with activation of the immune system leading to inflammation and excessive deposition of collagen in the skin, lungs, heart, gastrointestinal tract and kidneys. The females are more affected, especially after childbirth may be because of the hypothesis of microchimerism. The pathogenesis being a two way migration of fetal cells through the placenta. Although it cannot be cured completely but treatment with corticosteroids is helpful. The complications were preeclampsia, preterm labor, fetal growth restriction, eclampsia, thrombocytopenia and infections like pneumonia, sepsis like syndrome. The maternal mortality rate is approximately around 325/100000. We encountered a similar case of mixed connective tissue disorder in a patient aged 24 years at 29 weeks of gestation. The patient had conceived spontaneously after 5 yrs of diagnosis and had presented with all the known complications of the disease including lung fibrosis, FGR, preeclampsia and ascites. However she delivered and thereafter stabilized, although her baby had to be treated for a prolonged period at the NICU.

References

Peaceman AM, Ramsey-Goldman R. Autoimmune Connective Tissue Disease in Pregnancy

Chakravarty EF, Khanna D, Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 2008; 111(4): 927-34. https://doi.org/10.1097/01.AOG.0000308710.86880.a6

Narendhran N, Hameed J, Abhinaya, Salgun V. Mixed connective tissue disorder with pregnancy.

Kitridou RC. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus 1982; 9(4): 549-55.

Yildirim A, Tunaoolu FS, Karaaoac AT. Indian Pediatr 2013; 50(5): 483-8. https://doi.org/10.1007/s13312-013-0156-3

Tardif ML, Mahone M. Mixed connective tissue disease in pregnancy: A case series and systematic literature review.

Vengetesh PM, Hebbar S, Rai L. Autoimmune diseases in pregnancy: maternal and fetal outcomes.

Marder W, Littlejohn EA, Somers EC. Pregnancy and autoimmune connective tissue diseases.

Radin M, et al. Pregnancy Outcomes in Mixed Connective Tissue Disease: Results from a Multicentre Cohort Study.

Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro MT, Danieli. Pregnancy Outcomes in Mixed Connective Tissue Disease: Results from a Multicentre Cohort Study.

Downloads

Published

2020-04-26

Issue

Section

Articles